|
Video: What is a Stock Split?
|
|
Telesis Bio manufactures and sells laboratory equipment, synthetic biology instruments, reagents and associated products and related services to pharmaceutical and academic laboratories. Co.'s solutions include: BioXp 3250 and BioXp 9600 systems, which are an end-to-end automated workstation that enables researchers to go from a DNA sequence to endpoint-ready DNA; BioXp DBC, which is an enzymatic DNA synthesis with design to endpoint-ready synthetic RNA; BioXp portal, which is an online portal that provides guided workflow and design tools for building new DNA sequences; and BioXp De Novo kits, contain the building blocks and reagents for synthetic biology workflow applications. According to our Telesis Bio stock split history records, Telesis Bio has had 0 splits. | |
|
Telesis Bio (TBIO) has 0 splits in our Telesis Bio stock split history database.
Looking at the Telesis Bio stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Telesis Bio shares, starting with a $10,000 purchase of TBIO, presented on a split-history-adjusted basis factoring in the complete Telesis Bio stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/21/2021 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$19.94 |
|
End price/share: |
$0.45 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.74% |
|
Average Annual Total Return: |
-74.59% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$225.72 |
|
Years: |
2.77 |
|
|
|
|
|